Results 141 to 150 of about 153,000 (334)

The use of cardiac biomarkers in veterinary medicine: the equine perspective [PDF]

open access: yes, 2012
In human medicine, cardiac biomarkers, such as natriuretic peptides and troponins, are routinely used for the diagnosis, prognosis and monitoring of heart diseases.
De Clercq, Dominique   +4 more
core   +1 more source

Evaluation of serum concentration of cardiac troponin i in normal racing thoroughbred horses [PDF]

open access: yesEurasian Journal of Veterinary Sciences
Aim: Evaluation of serum concentration of cardiac troponin I in racing thoroughbred horses. Materials and Methods: Serum concentration of troponin I was measured in 49 clinically healthy thoroughbred horses using commercial ELISA detection kits. Results:
Javad Tajik   +3 more
doaj  

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Diagnostic Value of Troponin I and T to Predict Mortality in Patients Undergoing Hemodialysis

open access: yesArchives of Anesthesia and Critical Care, 2018
Background: There is no known biomarker to predict the mortality risk in patients undergoing dialysis in the intensive care unit (ICU). Therefore, the current study aimed to determine the diagnostic value of troponin I and T in this respect.
Seyed Taghi Hashemi   +2 more
doaj  

Fast and slow isoforms of troponin I and troponin C [PDF]

open access: bronze, 1990
Karl‐Thomas HÄRTNER, Dirk Pette
openalex   +1 more source

Assessment of cardiac troponins status in patients on regular hemodialysis

open access: yesAdvanced Medical Journal
Background and objectives: heart disease is a significant contributor to both fatalities and health issues among patients undergoing regular hemodialysis.
Raman Ameer Muhammed   +1 more
doaj   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy